Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1978 Aug;53(8):674–676. doi: 10.1136/adc.53.8.674

Tetrahydrobiopterin therapy of atypical phenylketonuria due to defective dihydrobiopterin biosynthesis.

J Schaub, S Däumling, H C Curtius, A Niederwieser, K Bartholomé, M Viscontini, B Schircks, J H Bieri
PMCID: PMC1545051  PMID: 708106

Abstract

A patient with atypical phenylketonuria (defective BH2 synthesis), detected at age 6 months because of severe muscle hypotonia and serum phenylalanine of 20 mg/100 ml, had normal activities of phenylalanine-4-hydroxylase and DHPR in liver biopsy, but only 2% activity in the phenylalanine-4-hyroxylase in vivo test using deuterated phenylalanine. After IV administration of 2.5 mg/kg chemically pure tetrahydrobiopterin bishydrochloride (BH4 . 2HCl), serum phenylalanine decreased from 20.4 to 2.1 mg/100 ml within 3 hours. Administration of 25 mg BH4 . HCl and 100 mg ascorbic acid through a gastric tube decrease; serum phenylalanine from 13.7 to less than 1.6 mg/100 ml within 3 hours and it remained less than 2 mg/100 ml for 2 days.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartholomé K., Byrd D. J., Kaufman S., Milstien S. Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro. Pediatrics. 1977 May;59(5):757–761. [PubMed] [Google Scholar]
  2. Bartholomé K., Lutz P., Bickel H. Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia. Pediatr Res. 1975 Dec;9(12):899–903. doi: 10.1203/00006450-197512000-00006. [DOI] [PubMed] [Google Scholar]
  3. Curtius H. C., Völlmin J. A., Baerlocher K. The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism. Clin Chim Acta. 1972 Mar;37:277–285. doi: 10.1016/0009-8981(72)90442-1. [DOI] [PubMed] [Google Scholar]
  4. Curtius H. C., Zagalak M. J., Baerlocher K., Schaub J., Leimbacher W., Redweik U. In vivo studies of the phenylalanine-4-hydroxylase system in hyperphenylalaninemics and phenylketonurics. Helv Paediatr Acta. 1978 Feb;32(6):461–469. [PubMed] [Google Scholar]
  5. Danks D. M., Cotton R. G., Schlesinger P. Letter: Tetrahydrobiopterin treatment of variant form of phenylketonuria. Lancet. 1975 Nov 22;2(7943):1043–1043. doi: 10.1016/s0140-6736(75)90335-9. [DOI] [PubMed] [Google Scholar]
  6. Kaufman S., Holtzman N. A., Milstien S., Butler L. J., Krumholz A. Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med. 1975 Oct 16;293(16):785–790. doi: 10.1056/NEJM197510162931601. [DOI] [PubMed] [Google Scholar]
  7. Kettler R., Bartholini G., Pletscher A. In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin. Nature. 1974 May 31;249(456):476–478. doi: 10.1038/249476a0. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES